22 - CLAP

1672. Scolnik D, Kozer E, Jacobson S, Diamond S,Young NL. Comparison of oral versus normal and highdoserectal acetaminophen in the treatment of febrile children. Pediatrics. 2002 Sep;110(3):553-6.1673. Watts R, Robertson J,Thomas G. Nursing management of fever in children: a systematic review. Int JNurs Pract. 2003 Feb;9(1):S1-8.Nistatina1674. Alban J. Efficacy of nystatin topical cream in the management of cutaneous candidiasis in infants. CurrTher Res Clin Exp. 1972 Apr;14(4):158-61.1675. Benjamin DK Jr, DeLong ER, Steinbach WJ, Cotton CM, Walsh TJ, Clark RH. Empirical therapy forneonatal candidemia in very low birth weight infants. Pediatrics. 2003 Sep;112(3 Pt 1):543-7.1676. Beveridge GW, Fairburn E, Finn OA, Scott OL, Stewart TW, Summerly R.A comparison of nystatincream with nystatin/triamcinolone acetonide combination cream in the treatment of candidal inflammationof the flexures. Curr Med Res Opin. 1977;4(8):584-7.1677. Blaschke-Hellmessen R, Schwarze R, Schmeiser H, Weigl I. Orally administered nystatin to newborninfants in the prevention of candidiasis. Z Gesamte Hyg. 1976 Jul;22(7):501-9.1678. Harris LJ, Pritzker HG, Eisen A, Steiner JW, Shack L. The effect of nystatin (mycostatin) on neonatalcandidiasis (thrush): a method of eradicating thrush from hospital nurseries. Can Med Assoc J. 1958Dec 1;79(11):891-6.1679. Kozinn PJ, Taschdjian CL, Dragutsky D, Minsky A. Treatment of cutaneous candidiasis in infancy andchildhood with nystatin and amphotericin B. Antibiot Annu. 1956-1957;:128-34.1680. Miller JM. Fungal Infections: Nystatin. In Ïnfectious Diseases of the Fetus and Newborn Infant”3th Ed.Remington Js and Klein JO Eds.WB Saunders, Philadelphia 1990, p 5031681. Munz D, Powell KR, Pai CH.Treatment of candidal diaper dermatitis: a double-blind placebo-controlledcomparison of topical nystatin with topical plus oral nystatin. J Pediatr. 1982 Dec;101(6):1022-5.1682. No authors listed. Nystatin prophylaxis. Orv Hetil. 1978 Jun 4;119(23):1448.1683. Quintiliani R, Owens NJ, Quercia RA, Klimek JJ, Nightingale CH. Treatment and prevention oforopharyngeal candidiasis. Am J Med. 1984 Oct 30;77(4D):44-8.1684. Schwarze R, Blaschke-Hellmessen R, Hinkel GK,Weigl I, Hoffmann H. Moniliasis prevention in newborninfants. II. Effectivity of general nystatin prevention in premature infants and hypotrophic newborninfants in a newborn intensive care unit. Kinderarztl Prax. 1979 Mar;47(3):135-42.1685. Suprihatin SD, Kartanegara D, Pauntu A, Damayanti A. Nystatin in the treatment of candidiasis. PaediatrIndones. 1969 Jan-Feb;9(1):13-6.Sales de rehidratación oral (SRO)1686. Alam NH, Hamadani JD, Dewan N, Fuchs GJ. Efficacy and safety of a modified oral rehydration solution(ReSoMaL) in the treatment of severely malnourished children with watery diarrhea. J Pediatr.2003 Nov; 143(5): 614-9.1687. Ali M, Dutta K, Chatterjee R, Ghosh S, Biswas R. Efficacy of oral rehydration therapy in dehydratingdiarrhoea of children. J Indian Med Assoc. 2003 Jun; 101(6): 352, 354, 356 passim.1688. Ahmed FU, Rahman ME, Mahmood CB. Mothers’ skills in preparing oral rehydration salt solution.Indian J Pediatr. 2000 Feb; 67(2): 99-102.1689. Avery ME, Snyder JD. Oral therapy for acute diarrhea.The underused simple solution. N Engl J Med.1990 Sep 27; 323(13): 891-4.1690. Bhan MK, Mahalanabis D, Fontaine O, Pierce NF. Clinical trials of improved oral rehydration saltformulations: a review. Bull World Health Organ. 1994; 72(6): 945-55.1691. CHOICE Study Group. Multicenter, randomized, double-blind clinical trial to evaluate the efficacy andsafety of a reduced osmolarity oral rehydration salts solution in children with acute watery diarrhea.Pediatrics. 2001 Apr; 107(4): 613-8.MANUAL CLÍNICO AIEPI NEONATAL 226